Company / AR per Share
Acadia Pharmaceuticals AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.73
FY2025
5-year range
$0.39 / $0.73
FY2021-FY2025
Trend
+21.5%
vs FY2024
Sector context
#57 of 115
Health Care
What the data says
At $0.73, Acadia Pharmaceuticals's ar per share ranks #57 of 115 in the Health Care sector. AR per Share has fluctuated over the past 10 years, ranging from $0.06 in FY2016 to $0.73 in FY2025.
Based on SEC 10-K filings.
0.73 in FY2025 with a 5-year CAGR of +18.6%.
Improved from $0.61 to $0.73 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +23.6%
- 5-Year CAGR
- +18.6%
- 10-Year CAGR
- -
Sector benchmark
#57 of 115 in Health CareTop 50% of 115This company $0.73 Sector average $27.05
▼
-97.3% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 21.5% year-over-year.
- Ranks #57 out of 115 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.73 | +21.5% |
| FY2024 | $0.60 | -1.1% |
| FY2023 | $0.61 | +57.0% |
| FY2022 | $0.39 | -4.2% |
| FY2021 | $0.40 | +29.8% |
| FY2020 | $0.31 | +24.9% |
| FY2019 | $0.25 | +18.6% |
| FY2018 | $0.21 | +46.8% |
| FY2017 | $0.14 | +146.8% |
| FY2016 | $0.06 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026